| Cardiomeds, an mHealth App for Self-Management to Support Swiss Patients With Heart Failure : 2-Stage Mixed Methods Usability Study | JMIR formative research |  | | 2025 | 11 | 61 |
|
| Swiss-Meds: An App Fostering Medication Adherence of Swiss Patient | Studies in health technology and informatics | | | 2019 | 218 | 516 |
|
| SMART-MEDS: Development of a Medication Adherence App for Acute Coronary Syndrome Patients based on a Gamified Behaviour Change Model | AMIA Annual Symposium proceedings | | | 2018 | 427 | 214 |
|
| P-glycoprotein: a clue to vitamin K antagonist stabilization | Pharmacogenomics |  | | 2015 | 707 | 0 |
|
| Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital | European journal of clinical pharmacology | | | 2013 | 881 | 1,290 |
|
| Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model | Basic & clinical pharmacology & toxicology | | | 2013 | 606 | 3 |
|
| Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment | Pharmacogenomics | | | 2013 | 696 | 0 |
|
| Anticoagulation par antivitamines K: analyse des interactions médicamenteuses et des polymorphismes génétiques à l'origine de la variabilité de la réponse et des risques liés à l'acénocoumarol | | | | 2012 | 911 | 1,498 |
|
| Introduction de l'acénocoumarol à l'aide d'un algorithme de prescription | Revue médicale suisse | | | 2010 | 631 | 0 |
|
